CHICAGO, June 7, 2011 /PRNewswire/ -- Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Safety Insurance Group, Inc. (Nasdaq: SAFT) and Endurance Specialty Holdings Ltd. (NYSE: ENH). Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: China Shengda Packaging Group Inc. (Nasdaq: CPGI) and MAKO Surgical Corp. (Nasdaq: MAKO). To see the full Zacks #5 Rank List - Stocks to Sell Now visit: http://at.zacks.com/?id=92

(Logo:  http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.

Here is a synopsis of why SAFT and ENH have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:

Safety Insurance Group, Inc. (Nasdaq: SAFT) announced first -quarter loss of 23 cents per share on May 4 that missed analysts' expectations by 133%. This apart the earnings also missed the previous year's results by 69%. The Zacks Consensus Estimate for the current year slipped 35 cents to $3.02 per share in the last 60 days. Next year's estimate dipped a couple of cents to $3.29 per share in that time span.

Endurance Specialty Holdings Ltd. (NYSE: ENH) posted a first-quarter loss of $2.42 per share on May 2, which came in 18 cents wider than the average forecast. The diluted earnings per share fell 147% to a loss of $2.25 on March 2011 as compared to results of March 2010. The Zacks Consensus Estimate for the full year fell $1.17 per share to a profit of 49 cents per share over the past month reflecting cuts by all the 7 covering analysts. For 2012, analysts expect a profit of $5.00 per share, compared to projections of a profit of $5.03 per share in a span of 7 days.  

Here is a synopsis of why CPGI and MAKO have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;

China Shengda Packaging Group Inc.'s (Nasdaq: CPGI) first-quarter earnings of 9 cents per share, posted on May 13, lagged analysts' projections by nearly 36%. For 2011, the Zacks Consensus Estimate moved down 26 cents to a profit of 32 cents per share in the last 30 days as both the covering analysts cut back on forecasts. Estimate for next year slid 37 cents to a profit of 41 cents per share during the same time span.

MAKO Surgical Corp. (Nasdaq: MAKO) reported a first-quarter loss of 27 cents per share on May 3, that fell 12% short of the Zacks Consensus Estimate. The full-year average forecast is currently pegged at a loss of 83 cents per share, compared to projections of a loss of 81 cents per share made 30 days back. Next year's forecast dropped 1 cent to a loss of 33 cents per share in the same period.

Truly taking advantage of the Zacks Rank requires the understanding of how it works.  The free special report; "Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions" is available to provide this insightful background. Download a free copy now to prosper in the years to come at http://at.zacks.com/?id=93

About the Zacks Rank

Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +28%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (2.8% versus +9.7%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=94

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=95

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch  

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer:  Past performance does not guarantee future results.  Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

SOURCE Zacks Investment Research, Inc.

Copyright 2011 PR Newswire

Mako Surgical Corp. (MM) (NASDAQ:MAKO)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Mako Surgical Corp. (MM) 차트를 더 보려면 여기를 클릭.
Mako Surgical Corp. (MM) (NASDAQ:MAKO)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Mako Surgical Corp. (MM) 차트를 더 보려면 여기를 클릭.